BYDUREON is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus and should be used along with diet and exercise. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
BYDUREON is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus and should be used along with diet and exercise.
BYDUREON is a long-acting form of the medication contained in BYETTA. Do not use BYDUREON and BYETTA together.
BYDUREON is not recommended as the first choice of medication for treating diabetes.
BYDUREON is not insulin.
It is not known if BYDUREON is safe and effective when used with insulin.
BYDUREON is not for use in people with type 1 diabetes or people with a condition caused by very high blood sugar (diabetic ketoacidosis).
It is not known if BYDUREON is safe and effective in children. BYDUREON is not recommended for use in children.
It is not known if BYDUREON is safe and effective in people who have a history of pancreatitis.
BYDUREON has not been studied in people who have severe kidney problems.
Bydureon (Exenatide) injection suppliers in India. Allevaire India Network New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
The order for Bydureon (Exenatide) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settingsBYDUREON is an extended-release formulation of exenatide. Do not co-administer with BYETTA.
Limitation of Use:
Not recommended as first-line therapy for patients inadequately controlled on diet and exercise
Should not be used to treat type 1 diabetes or diabetic ketoacidosis
Use with insulin has not been studied and is not recommended
Has not been studied in patients with a history of pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis
Medicine Name: BYDUREON
Generic Name: Exenatide
Approval Date: 02/28/2014
Company Name: Amylin Pharmaceuticals, Inc.
Available as (Form & Strength): 2 mg exenatide for extended-release injectable suspension.
Bydureon (exenatide) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Bydureon (Exenatide) on prescription and Import License in Patient’s Name only.
For foreign countries patients,Bydureon (Exenatide) Injection can be made available in Send your enquiry to find Bydureon (Exenatide) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Bydureon (Exenatide) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details